- Company Directors - B
- Burrill Steven
Insider Trading History of Burrill Steven
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Burrill Steven since 2007.
The trader's CIK number is 1198177.
At the time of the last reporting, Burrill Steven was the Officer of Catalyst Biosciences, Inc.. (stock ticker symbol CBIO).
Also see all insider trading activities at Catalyst Biosciences, Inc..
Note that in the past
BURRILL STEVEN also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Pharmasset Inc (VRUS) by Burrill Steven
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | VRUS | 222,222 | $1,999,998 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Assertio Therapeutics, Inc (DEPO) by Burrill Steven
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | DEPO | 0 | $0 | 156,250 | $1,277,774 | 141,250 | $632,792 |
| 2009 | DEPO | 0 | $0 | 0 | $0 | 15,000 | $43,125 |
| 2008 | DEPO | 40,000 | $61,240 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Vaxgen Inc (DDXS) by Burrill Steven
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | DDXS | 219,087 | $87,221 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Catalyst Biosciences, Inc. (TRGT) by Burrill Steven
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | TRGT | 0 | $0 | 0 | $0 | 4,333 | $324 |
| 2011 | TRGT | 0 | $0 | 52,000 | $1,245,690 | 50,000 | $393,900 |
| 2007 | TRGT | 0 | $0 | 0 | $0 | 1,000 | $75 |
Insider trading activities at 4 companies by Burrill Steven:
1. Pharmasset Inc (VRUS)
2. Assertio Therapeutics, Inc (DEPO)
3. Vaxgen Inc (DDXS)
4. Catalyst Biosciences, Inc. (TRGT)
Table 1. Insider trading of Pharmasset Inc (VRUS) by Burrill Steven
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-05-02 | VRUS | Buy | 222,222 | 9.00 | 1,999,998 |
Table 2. Insider trading of Assertio Therapeutics, Inc (DEPO) by Burrill Steven
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-05-12 | DEPO | Option Ex | 62,000 | 5.32 | 329,964 |
| 2011-05-13 | DEPO | Option Ex | 69,250 | 3.88 | 268,828 |
| 2011-05-12 | DEPO | Sale | 87,000 | 8.25 | 717,750 |
| 2011-05-13 | DEPO | Sale | 69,250 | 8.09 | 560,024 |
| 2011-04-04 | DEPO | Option Ex | 10,000 | 3.40 | 34,000 |
| 2009-07-10 | DEPO | Option Ex | 15,000 | 2.88 | 43,125 |
| 2008-11-26 | DEPO | Buy | 40,000 | 1.53 | 61,240 |
Table 3. Insider trading of Vaxgen Inc (DDXS) by Burrill Steven
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-02-03 | DDXS | Buy | 15,287 | .40 | 6,114 |
| 2011-01-21 | DDXS | Buy | 55,500 | .40 | 22,200 |
| 2011-02-02 | DDXS | Buy | 15,000 | .40 | 6,000 |
| 2011-02-01 | DDXS | Buy | 15,300 | .39 | 5,967 |
| 2011-01-28 | DDXS | Buy | 13,000 | .38 | 4,940 |
| 2011-01-24 | DDXS | Buy | 100,000 | .40 | 40,000 |
| 2011-02-07 | DDXS | Buy | 5,000 | .40 | 2,000 |
Table 4. Insider trading of Catalyst Biosciences, Inc. (TRGT) by Burrill Steven
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-07-31 | TRGT | Option Ex | 4,333 | .07 | 324 |
| 2011-05-11 | TRGT | Sale | 33,052 | 23.88 | 789,347 |
| 2011-05-10 | TRGT | Sale | 18,948 | 24.08 | 456,343 |
| 2011-05-11 | TRGT | Option Ex | 33,052 | 7.11 | 235,098 |
| 2011-05-10 | TRGT | Option Ex | 16,948 | 9.37 | 158,802 |
| 2007-03-05 | TRGT | Option Ex | 1,000 | .07 | 75 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Burrill Steven
(Officer of Catalyst Biosciences, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.